News

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.
Revvity serves the pharmaceutical and biotech industries, diagnostic labs, academia. and governments in more than 160 ...
Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...
"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...
Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.
The scientists used a combination of short- and long-read sequencing data to assemble and analyze genomes from 28 members of the same family.
Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.
The team tested the impact on eight novel helper plasmids with different deletions in the E2 and E4 genes on four rAAV serotypes. They discovered that some deletions affected productivity, reducing ...
Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.
One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.
In The State of CRISPR and Genome Editing virtual summit, GEN brings together an outstanding line-up of pioneers and ...